Patient Condition
Malattia cardiaca ipertensiva con HFrEF, LVEF 32%, NYHA classe III, controllo scadente a lungo termine dell 'ipertensione porta a ipertrofia ventricolare sinistra e dilatazione. Diabete di tipo 2 concomitante e malattia renale cronica (eGFR 55 mL / min).
Treatment Timeline
| Phase | Details | Date |
|---|
| 多学科评估 | | |
| ARNI+SGLT2i启动 | | |
| 综合代谢管理 | | |
| 维持与随访 | | |
Treatment Outcome
| before | LVEF 32%，NYHA III级，NT-proBNP 3600 pg/mL，HbA1c 8.2%，eGFR 55 mL/min |
|---|
| after | LVEF 48%，NYHA I-II级，NT-proBNP 980 pg/mL，HbA1c 6.8%，eGFR 52 mL/min |
|---|
| highlight | ARNI+SGLT2i在心肾代谢综合征患者中实现心功能、血糖、肾功能三重获益 |
|---|